| Quarter | Score |
|---|---|
| 2022-Q1 | 51.8 |
| 2022-Q3 | 68.7 |
| 2022-Q4 | 49.2 |
| 2023-Q2 | 41.6 |
| 2023-Q3 | 50.1 |
| 2023-Q4 | 66.7 |
| 2024-Q1 | 60.5 |
| 2024-Q2 | 54.2 |
| 2024-Q3 | 83.8 |
| 2024-Q4 | 81.5 |
| 2025-Q1 | 65.6 |
| 2025-Q2 | 68.9 |
| 2025-Q3 | 81.5 |
| 2025-Q4 | 80.8 |
| 2026-Q1 | 80.0 |
| 2026-Q2 | 80.0 |
High consensus with active accumulation at an attractive valuation
Trading 18.7% below funds' estimated purchase price
2 of 18 tracked funds hold KHC. Avg conviction: 1.3%. Net adding. First tracked at $29.13 (current -18.7% vs tracked).
Berkshire Hathaway has 2.6% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Berkshire Hathaway | 2.6% | Hold |
| Citadel Advisors | 0.0% | Add |